Alternative Cephalosporins and Their Dosing Regimens for Various Infections
Cephalosporins are classified by generations, with each offering different antimicrobial coverage profiles, and should be selected based on the suspected pathogen and infection site.
Second-Generation Cephalosporins
Cefuroxime Axetil (Oral)
Respiratory Tract Infections:
Urinary Tract Infections:
Skin and Soft Tissue Infections:
- 250-500 mg PO twice daily for 5-10 days 2
Lyme Disease:
- Early stage (erythema migrans): 500 mg PO twice daily for 14-21 days 2
Cefuroxime (IV)
- Moderate to Severe Infections:
Third-Generation Cephalosporins
Cefixime (Oral)
Respiratory Tract Infections:
Urinary Tract Infections:
- Uncomplicated UTI: 400 mg PO once daily 8
Gonorrhea:
- Uncomplicated: 400 mg PO as a single dose 8
Ceftriaxone (IV/IM)
Respiratory Tract Infections:
Meningitis:
- 2 g IV every 12 hours 7
Skin and Soft Tissue Infections:
- 1-2 g IV/IM once daily 7
Gonorrhea:
- Uncomplicated: 1.5 g IM as a single dose at 2 different sites with 1 g oral probenecid 6
Infective Endocarditis:
- 100 mg/kg/day IV divided every 12 hours or 80 mg/kg/day IV every 24 hours (up to 4 g daily) 7
Dosing Adjustments for Special Populations
Renal Impairment (Cefuroxime)
- CrCl >20 mL/min: Standard dose
- CrCl 10-20 mL/min: 750 mg every 12 hours
- CrCl <10 mL/min: 750 mg every 24 hours 6
Pediatric Dosing (Cefuroxime)
- Children >3 months: 50-100 mg/kg/day IV divided every 6-8 hours
- Severe infections: 100 mg/kg/day (not exceeding adult dose)
- Bone/joint infections: 150 mg/kg/day divided every 8 hours
- Bacterial meningitis: 200-240 mg/kg/day IV divided every 6-8 hours 6
Comparative Efficacy and Selection Criteria
When choosing between cephalosporins, consider:
Spectrum of Activity:
Specific Pathogen Considerations:
Route of Administration:
Adverse Effects:
- Cefuroxime axetil has fewer gastrointestinal adverse events (10%) compared to cefixime (18%), particularly diarrhea (5% vs 15%) 4
Common Pitfalls and Caveats
Resistance Concerns: Resistance rates vary significantly between generations, with first-generation cephalosporins showing up to 96% resistance among viridans group streptococci versus 17% for third-generation 8
Cross-Reactivity: Patients with severe penicillin allergies may experience cross-reactivity with cephalosporins
Oral Bioavailability: Cefuroxime axetil has approximately 68% bioavailability when taken with food 1
Duration of Therapy: For most respiratory infections, 5-7 days is sufficient if the patient becomes afebrile within 48 hours and has no more than one sign of clinical instability 7
Sequential Therapy: For hospitalized patients with pneumonia, consider IV cefuroxime (750 mg 2-3 times daily for 2-5 days) followed by oral cefuroxime axetil (500 mg twice daily for 3-8 days) 2